Thaer Abdelfattah, MD
Gastroenterology · Providence, RINPI 1346796091
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.2%), travel and lodging and education — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Boston Scientific at 30.5% of the total. Reporting peaked in 2024 at $5,919 and has fallen 69.5% since, to $1,806 in 2025.
Across 330 payments — averaging $51.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$5K
- Olympus Corporation Of The Americas$4K
- AbbVie$2K
- Johnson & Johnson$1K
- Takeda Pharmaceuticals U.S.A., Inc.$688
- Ovesco Endoscopy USA, Inc.$549
- plus $3K from 21 others
What the payments were for
- Travel & lodging$8,04048%
- Food & beverage$8,46950%
- Education$3492%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 39 | $5,143 |
| Olympus Corporation Of The Americas | 37 | $4,359 |
| AbbVie | 92 | $2,029 |
| Johnson & Johnson | 41 | $1,173 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $688 |
| Ovesco Endoscopy USA, Inc. | 1 | $549 |
| Gilead | 18 | $431 |
| Micro-tech Endoscopy USA, Inc. | 3 | $393 |
| Phathom Pharmaceuticals, Inc. | 12 | $380 |
| Pfizer | 15 | $281 |
| Bristol Myers Squibb | 11 | $276 |
| Ardelyx, Inc. | 8 | $230 |
| Lilly USA, LLC | 9 | $208 |
| QOL Medical, LLC | 1 | $123 |
| Olympus America Inc. | 1 | $120 |
| Fujifilm Healthcare Americas Corporation | 1 | $75 |
| Madrigal Pharmaceuticals | 3 | $63 |
| Braintree Laboratories, Inc. | 2 | $55 |
| Aimmune Therapeutics, Inc. | 2 | $54 |
| Celltrion USA Inc. | 2 | $44 |
| Ferring Pharmaceuticals Inc. | 2 | $40 |
| Lucid Diagnostics Inc. | 2 | $37 |
| Intercept Pharmaceuticals, Inc. | 1 | $26 |
| Apollo Endosurgery US Inc | 1 | $22 |
| Medtronic | 1 | $20 |
| Ironwood Pharmaceuticals, Inc | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Single Use Electrosurgical Knife KD-655$3,186
- DISPOSABLE DISTAL ATTACHMENT$3,186
- Olympus$2,671
- ACQUIRE$1,475
- VISIGLIDE$1,312
- GENERAL - THERAPIES$1,078
- Single Use Aspiration Needle NA-U200H$673
- Skyrizi$481
- Single Use Electrosurgical Hemostatic Forceps$351
- EXALT Model D$141
- SPYGLASS$133
- Sucraid$123
- AXIOS$122
- VOQUEZNA$122
- Creon$101
- Entyvio$100
How this compares
$16,858 in reported general payments places this provider in the 85th percentile of 85 gastroenterology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 98 | $2,041 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 107 | $1,619 |
| Desipramine Hcl | 12 | $712 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 11 | $160 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Providence
- Thomas SepeProvidence$307K
- Paul AkermanProvidence$123K
- Sean FineProvidence$55K
- Breton RousselProvidence$50K
- Alan EpsteinProvidence$36K
- Samir ShahProvidence$28K
- Lisa MuellerProvidence$25K
- Nabil ToubiaProvidence$20K
- Eric NewtonProvidence$16K
- William ChenProvidence$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.